ClinicalTrials.Veeva

Menu

Adrenal Tumors - Pathogenesis and Therapy

U

University of Wuerzburg

Status

Enrolling

Conditions

Conn Syndrome
Adrenocortical Carcinoma
Adrenal Tumors
Cushing Syndrome
Pheochromocytoma

Study type

Observational

Funder types

Other

Identifiers

NCT00669266
Wue-Adrenal-Tumors-92/2002

Details and patient eligibility

About

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Enrollment

500 estimated patients

Sex

All

Ages

Under 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • adrenal tumor detected by imaging

Exclusion Criteria:

Trial design

500 participants in 2 patient groups

Tumor
Description:
Tumor material and corresponding biosamples from patients with adrenal tumors
control group
Description:
Biomaterial from patients without adrenal tumor

Trial contacts and locations

1

Loading...

Central trial contact

Martin Fassnacht, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems